SAB Biotherapeutics, Inc. (SABS)
NASDAQ·Healthcare·Biotechnology
$3.08
+1.65%
Mkt Cap $267.50M
Analyst Ratings
Buy
3
Hold
0
Sell
0
Price Target (8 analysts)
$11.33
Range $10.00 – $13.00
Implied Upside
+267.9%
Consensus $11.33 vs current $3.08
NASDAQ·Healthcare·Biotechnology
$3.08
+1.65%
Mkt Cap $267.50M
Buy
3
Hold
0
Sell
0
Price Target (8 analysts)
$11.33
Range $10.00 – $13.00
+267.9%
Consensus $11.33 vs current $3.08